Apogem Capital LLC United Therapeutics Corp Transaction History

Apogem Capital LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$174.81 - $241.14 $475,483 - $655,900	-2,720 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$166.16 - $213.96 $9,969 - $12,837	-60 Reduced 2.16%	2,720 $488,000
Q4 2021 Feb 14, 2022	SELL	$184.32 - $216.08 $79,626 - $93,346	-432 Reduced 13.45%	2,780 $601,000
Q3 2021 Nov 15, 2021	SELL	$179.86 - $214.88 $719 - $859	-4 Reduced 0.12%	3,212 $593,000
Q2 2021 Aug 16, 2021	SELL	$170.47 - $211.93 $186,323 - $231,639	-1,093 Reduced 25.37%	3,216 $577,000
Q1 2021 May 14, 2021	BUY	$153.94 - $174.85 $663,327 - $753,428	4,309 New	4,309 $721,000

671

42.3M

194K

295K

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $16.4B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

Get notified when there are updates to the investment portfolio of Apogem Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Apogem Capital LLC with notifications on news.